Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apyx Medical Corp Director's Dealing 2014

Sep 23, 2014

34303_dirs_2014-09-23_a14a29ed-8cf6-4287-8acc-3334858b3837.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOVIE MEDICAL CORP (BVX)
CIK: 0000719135
Period of Report: 2014-09-19

Reporting Person: SARON J ROBERT (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-09-19 Common Stock M 12500 $2.13 Acquired 399819 Direct
2014-09-19 Common Stock F 6121 $4.35 Acquired 393698 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-18 Stock Option (Option to Buy) $2.13 M 6379 Acquired 2014-09-23 Common Stock (12500) Direct

Footnotes

F1: Reflects 6,121 shares withheld by the issuer at the market price of $4.35 per share less an exercise price of $2.13 per share to fund the cashless exercise of 12,500 options owned by the reporting person.